12th Miltenyi Biotec Scientific Days France

Immuno-oncology: heterogeneous cells battling in the tumor microenvironment

Thursday, July 5 – Friday, July 6, 2018

Centre de Recherche des Cordeliers (CRC)
Campus des Cordeliers – Amphithéâtre Farabeuf
15 rue de l’école de médecine, 75006 Paris

Thursday, July 5
08:30 a.m.	Opening Daniel Louvard, France
08:45 a.m.	Heterogeneity of immune cells and cancer antigens in cancer vaccines and immunotherapy: mouse models and translation to human clinical trials (EATI Honorary Lecture 2018) Jay A. Berzofsky, USA
09:30 a.m.	Host-Microbiome interactions – reality or myth? Harry Sokol, France
10:00 a.m.	Programming tissue residency to enhance immunity to infection and tumors Ananda W. Goldrath, USA
10:30 a.m.	Coffee break
11:00 a.m.	Immunotherapy of cancer: clinical experimentation Fabrice André, France
11:30 a.m.	From initiation to treatment: microbial influences in carcinogenesis Christian Jobin, USA
12:00 p.m.	Lunch break
02:00 p.m.	Defining molecular identity of intratumoral T cells to design better cancer immunotherapies Sergio Abrignani, Italy
02:30 p.m.	Molecular and epigenetic programs defining tumor-specific T cell dysfunction Andrea Schietenger, USA
03:00 p.m.	Immune parameters for predicting patient outcome Christian Ottensmeier, UK
03:30 p.m.	Coffee break
04:00 p.m.	IL-18 drives immunosuppression in multiple myeloma Ludovic Martinet, France
04:30 p.m.	Induction and transcriptional regulation of the “co-inhibitory” gene module in T cells Vijay Kuchroo, USA
5:00 p.m.	Celebration party “20th Year Miltenyi Biotec France”
Friday, July 6
09:15 a.m.	Welcome Laurence Zitvogel / Guido Kroemer / Hervé Fridman, France
09:30 a.m.	The role of GM-CSF in graft-vs-host disease: uncoupling of GvHD and GvL immunity Burkhardt Becher, Switzerland
10:00 a.m.	Myeloid cells contribution to tumor outcome Miriam Merad, USA
10:30 a.m.	Coffee break
11:00 a.m.	Genetic screens to identify immunotherapy targets Nicholas Haining, USA
11:30 a.m.	Cancer evolution and immune escape: TRACERx Rachel Rosenthal, UK
12:00 p.m.	Lunch break
02:00 p.m.	Dynamics of epigenetic traits in triple-negative breast cancer Céline Vallot, France
02:30 p.m.	Single-cell transcriptomic network inference as a new approach to better characterize autoinflammatory diseases Mickaël Ménager, France
03:00 p.m.	Molecular basis of T cell exhaustion: insights for immunotherapy E. John Wherry, USA
03:30 p.m.	Coffee break
04:00 p.m.	Metabolic interventions for the immunoprophylaxis of breast cancer Guido Kroemer, France
04:30 p.m.	Closing / Farewell Jean Magon, France